The Assisi think tank focus review on postoperative radiation for lobular breast cancer
O Kaidar-Person,I Ratosa,P Franco,V Masiello,F Marazzi,S Pedretti,A Ciabattoni,M C Leonardi,T Tramm,C E Coles,I Meattini,M Arenas,B V Offersen,L J Boersma,V Valentini,D Dodwell,P Poortmans,C Aristei,Assisi Think Tank Meeting ATTM investigators,Simona Borghesi,David Krug,Angel Montero Luis,Valerio Nardone,Yasemin Bölükbaşi,Vassilis Kouloulias,Isabella Palumbo,Elisabetta Perrucci,Sofia Rivera,Laura Lozza,Marco Krengli,Lurdes Trigo
DOI: https://doi.org/10.1016/j.radonc.2024.110573
2024-10-11
Abstract:The "Assisi Think Tank Meeting" (ATTM) on Breast Cancer, endorsed by the European Society for Radiotherapy & Oncology (ESTRO) and the Italian Association of Radiotherapy and Clinical Oncology (AIRO), and conducted under the auspices of the European Society of Breast Cancer Specialists (EUSOMA), is a bi-annual meeting aiming to identify major clinical challenges in breast cancer radiation therapy (RT) and proposing clinical trials to address them. The topics discussed at the meeting are pre-selected by the steering committee. At the meeting, these topics are discussed in different working groups (WG), after preparation of the meeting by performing a systematic review of existing data and of ongoing trials. Prior to the meeting, each WG designs a survey on the topic to be discussed to reflect current clinical practice and to identify areas requiring further research. Herein, we present the work done by the Assisi WG focusing on lobular carcinoma and the RT perspectives in its treatment, including providing recommendations for locoregional therapy, mainly RT for patients with non-metastatic lobular breast cancer.